Editorial

Editorial Introduction

Editorial     

Retaining Ethnic Minority Parents in a Preventive Intervention: The Quality of Group Process

This study examined relations between group process variables and retention of ethnic minority (African American and Hispanic) caregivers in a family-focused preventive intervention. Data from the Familias Unidas/SEPI project (Coatsworth, Pantin, & Szapocznik, 2002), a randomized, controlled intervention trial, were used to cluster participants according to their patterns of retention over 30 intervention sessions. These person-centered analyses identified three broad patterns: (a) dropouts; (b) variable-attenders; and (c) consistent-high-attenders. Two subgroups of the variable-attender group were also identified: (a) intermittent-attenders, and (b) continual-attenders. Discriminant Function Analysis (DFA) with follow-up Analysis of Variance tested for differences among the three main retention groups on facilitator ratings of participants' general level of participation, leadership, positive alliance with the group, and negative alliance with the group during the first half of the intervention. Leadership and positive alliance significantly discriminated the broad retention patterns. Mean level of participation was not significantly different across retention groups. Results of DFA and ANOVA analyses using leadership, alliance, and participation variables from the first and second halves of the intervention indicated only leadership and positive alliance during the second half of the intervention discriminated continual-attenders from intermittent-attenders. EDITORS' STRATEGIC IMPLICATIONS: The authors describe a promising approach to studying facilitators' assessments of client involvement in a family-focused preventive intervention. The quality of the participants' behavior during sessions, rather than their absolute levels of participation, predicted their pattern of retention in the program. Future comparisons of facilitator and parent views may prove helpful.     

Evaluation of a commercial enzyme‐linked immunosorbent assay for detection of antibodies against the H5 subtype of Influenza A virus in waterfowl

The ID Screen Influenza H5 Antibody Competition enzyme‐linked immunosorbent assay was tested for the detection of antibodies to the H5 subtype of influenza A (IA) virus in waterfowl. Assays were conducted with sera obtained from Mallards (Anas platyrhynchos) and Pekin Ducks (Anas platyrhynchos domestica), experimentally infected with eight low pathogenic (LP) and nine highly pathogenic (HP) H5N1 IA viral strains. Three incubation periods (1, 4 and 18 hours) and two dilutions (1:2 and 1:5) were tested. All serum samples from LP H5‐infected birds tested positive; however, improved detection rates were observed for viruses belonging to the HP H5N1 clade 2.2.1 as compared with those belonging to clade 2.1.3.     

Is the quality of asthma prescribing, as measured by the general practice ratio of corticosteroid to bronchodilator, associated with asthma morbidity?

The objective of this study was to determine whether the quality of asthma prescribing in general practice is associated with the severity of asthma patients' symptoms. Cross-sectional survey of asthma-like symptoms in patients prescribed antiasthma therapy was used. The setting was two general practices with contrasting ratios of corticosteroid to bronchodilator (high vs. low). The main outcome measures were: patient symptoms score and patient characteristics (age, gender, diagnosis, smoking, social class, and deprivation status). Patients on antiasthma therapy from the practice with the low corticosteroid to bronchodilator ratio had a higher mean symptom score (20.1, 95% CI 18.6, 21.7) than patients on antiasthma therapy from the practice with the high corticosteroid to bronchodilator ratio (13.2, 95% CI 11.8, 14.5). The mean difference in patient symptom score between the two practices was 7.0 (95% CI 4.9, 9.0); this changed little after adjustment for potential confounders. The quality of prescribing, as measured by the practice ratio of corticosteroid to bronchodilator, appears to be an important factor in the outcome of asthma care. The ratio of corticosteroid to bronchodilator in a general practice is one indicator of the quality of prescribing for asthma.     

Partnerships for the design, conduct, and analysis of effectiveness, and implementation research: experiences of the prevention science and methodology group

What progress prevention research has made comes through strategic partnerships with communities and institutions that host this research, as well as professional and practice networks that facilitate the diffusion of knowledge about prevention. We discuss partnership issues related to the design, analysis, and implementation of prevention research and especially how rigorous designs, including random assignment, get resolved through a partnership between community stakeholders, institutions, and researchers. These partnerships shape not only study design, but they determine the data that can be collected and how results and new methods are disseminated. We also examine a second type of partnership to improve the implementation of effective prevention programs into practice. We draw on social networks to studying partnership formation and function. The experience of the Prevention Science and Methodology Group, which itself is a networked partnership between scientists and methodologists, is highlighted.     

Adolescent Neurological Development and its Implications for Adolescent Substance Use Prevention

Recent technological advancements have facilitated the study of adolescent neurological development and its implications for adolescent decision-making and behavior. This article reviews findings from the adolescent neurodevelopment and substance use prevention literatures. It also discusses how findings from these two distinct areas of adolescent development can complement each other and be used to build more developmentally appropriate interventions for preventing adolescent substance use. Specifically, a combination of child-centered and family-based strategies is advocated based on extant neurological and prevention literature. Editors’ strategic implications: Researchers are encouraged to take up the authors’ challenge and study the links between adolescent neurological development/decision making ability and the long term efficacy of comprehensive interventions for preventing adolescent substance use.     

Two-Year Impact of Prevention Programs on Adolescent Depression: an Integrative Data Analysis Approach

This paper presents the first findings of an integrative data analysis of individual-level data from 19 adolescent depression prevention trials (n = 5210) involving nine distinct interventions across 2 years post-randomization. In separate papers, several interventions have been found to decrease the risk of depressive disorders or elevated depressive/internalizing symptoms among youth. One type of intervention specifically targets youth without a depressive disorder who are at risk due to elevated depressive symptoms and/or having a parent with a depressive disorder. A second type of intervention targets two broad domains: prevention of problem behaviors, which we define as drug use/abuse, sexual risk behaviors, conduct disorder, or other externalizing problems, and general mental health. Most of these latter interventions improve parenting or family factors. We examined the shared and unique effects of these interventions by level of baseline youth depressive symptoms, sociodemographic characteristics of the youth (age, sex, parent education, and family income), type of intervention, and mode of intervention delivery to the youth, parent(s), or both. We harmonized eight different measures of depression utilized across these trials and used growth models to evaluate intervention impact over 2 years. We found a significant overall effect of these interventions on reducing depressive symptoms over 2 years and a stronger impact among those interventions that targeted depression specifically rather than problem behaviors or general mental health, especially when baseline symptoms were high. Implications for improving population-level impact are discussed.